Kairos Pharma Ltd (AMEX:KAPA) has seen 728.67 shares traded in the last trading session. The company, currently valued at $10.45M, closed the last trade at $0.61 per share which meant it lost -$7.72 on the day or 0.62% during that session. The KAPA stock price is -555.74% off its 52-week high price of $4.00 and 34.43% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.13 million shares traded. The 3-month trading volume is 2.43 shares.

Kairos Pharma Ltd (AMEX:KAPA) trade information

Over the past 30 days, the shares of Kairos Pharma Ltd (AMEX:KAPA) have changed 5.08%. Short interest in the company has seen 19410.0 shares shorted with days to cover at 0.08.

Kairos Pharma Ltd (KAPA) estimates and forecasts

The company’s shares have lost -62.76% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -4.30% -23.37% over the past 5 years. Earnings growth for 2025 is a modest 7.25% while over the next 5 years, the company’s earnings are expected to decrease by -24.45%.

KAPA Dividends

Kairos Pharma Ltd is expected to release its next earnings report on 2025-May-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Kairos Pharma Ltd (AMEX:KAPA)’s Major holders

Insiders own 47.25% of the company shares, while shares held by institutions stand at 9.36% with a share float percentage of 17.75%. Investors are also buoyed by the number of investors in a company, with Kairos Pharma Ltd having a total of 8.0 institutions that hold shares in the company.